Suchergebnisse - "Müller, Martin C"

PubPharm (161)

1

Standardization of molecular monitoring of CML : results and recommendations from the European treatment and outcome study

enthalten in: Leukemia | 2022

von White, H. | Salmon, M. | Albano, F. | +58

2

SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment

enthalten in: Leukemia & lymphoma | 2022

von Egeli, D. | Hanfstein, B. | Lauseker, M. | +4

3

New Drug for Chronic Myeloid Leukemia Might Stimulate the Market

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Müller, M.

CommentIn: Clin Cancer Res. 2021 Jan 1;27(1):70-77. - PMID 32928796

4

The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis

enthalten in: Haematologica | 2020

von Godavarthy, P. | Kumar, R. | Herkt, S. | +15

CommentIn: Haematologica. 2020 Jan;105(1):2-4. - PMID 31894093

5

Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid Leukemia

enthalten in: The Journal of molecular diagnostics : JMD | 2020

von Franke, G. | Maier, J. | Wildenberger, K. | +6

6

Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia : final 5-year results of the phase 2 PACE trial

enthalten in: Blood | 2018

von Cortes, J. | Kim, D. | Pinilla-Ibarz, J. | +22

7

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI) : a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

enthalten in: The Lancet. Oncology | 2018

von Saussele, S. | Richter, J. | Guilhot, J. | +47

CommentIn: Lancet Oncol. 2018 Jun;19(6):717-718. - PMID 29735298

8

Defining therapy goals for major molecular remission in chronic myeloid leukemia : results of the randomized CML Study IV

enthalten in: Leukemia | 2018

von Saussele, S. | Hehlmann, R. | Fabarius, A. | +21

9

Ponatinib in chronic myeloid leukemia (CML) : Consensus on patient treatment and management from a European expert panel

enthalten in: Critical reviews in oncology/hematology | 2017

von Müller, M. | Cervantes, F. | Hjorth-Hansen, H. | +4

10

High BCR-ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2017

von Vigneri, P. | Stagno, F. | Stella, S. | +20

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]